Review: could Eligard cause Cyp2d6 polymorphism?
Summary: there is no Cyp2d6 polymorphism reported by people who take Eligard yet.
We study 238 people who have side effects while taking Eligard from FDA and social media. Find out below who they are, when they have Cyp2d6 polymorphism and more.
You are not alone: join a mobile support group for people who take Eligard and have Cyp2d6 polymorphism >>>
Eligard has active ingredients of leuprolide acetate. It is often used in prostate cancer. (latest outcomes from 631 Eligard users)
Cyp2d6 polymorphism (latest reports from 12 Cyp2d6 polymorphism patients)
On Mar, 2, 2015: No report is found
Do you have Cyp2d6 Polymorphism while taking Eligard?
You are not alone! Join a mobile support group on :
- support group for people who take Eligard
- support group for people who have Cyp2d6 polymorphism
Drugs in real world that are associated with:
Could your condition cause:
Recent Eligard related drug comparison:
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.